For citations:
Abdulrazzak S.A., Vorobyev A.N., Sinitsyna N.I., Sharutin I.V., Menshova O.V., Elizarova E.V., Ivanov Yu.V., Karamyan A.S., Abramovich R.A., Potanina O.G., Sakanyan K.M. Development of Dihydroquercetin-based Oral tablets and Evalution of the General Toxic Effect. Drug development & registration. 2022;11(2):126-138. (In Russ.) https://doi.org/10.33380/2305-2066-2022-11-2-126-138
Email this article 